Table 3 Preferred routes of administration and mode of access to cannabis-based extracts if medicinal cannabis became legally available (N = 65).
From: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
Preferred routes of administration | N (%) |
|---|---|
Oral use - Liquid (e.g. oil) | 44 (67.7%) |
Oral use - Tablets/capsules (swallowed) | 21 (32.3%) |
I do not care as long as it is effective | 18 (27.7%) |
Oral use - Chewable tablet | 11 (16.9%) |
Mouth spray | 9 (13.8%) |
Via the nose - intranasal spray | 6 (9.2%) |
Via the nose - Inhalant (e.g. like “Vick’s vapor”) | 5 (7.7%) |
Skin patches | 5 (7.7%) |
Edible (e.g., butter/resin, tea infusion) | 2 (3.1%) |
Smoked – Joint | 2 (3.1%) |
Vaporiser | 2 (3.1%) |
Suppository | 2 (3.1%) |
Other: Raw cannabis material for juicing | 1 (1.5%) |
Other: Slow-release tablet administered once daily | 1 (1.5%) |
Smoked - Water pipe (“bong”) | — |
Preferred mode of access | |
From a pharmacy like other medication | 52 (80%) |
From a special licensed cannabis dispensary | 16 (24.6%) |
I do not care as long as there is regular supply | 9 (13.8%) |
Grow or make your own | 7 (10.8%) |
From a supplier | 5 (7.7%) |
Trade/buy from a friend | 2 (3.1%) |
No opinion | 1 (1.5%) |
Other: Sold as a supplement | 1 (1.5%) |
